These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 5524258)

  • 1. The role of distribution as a determinant of central anticholinergic specificity in a series of oxotremorine analogs.
    Karlén B; Jenden DJ
    Res Commun Chem Pathol Pharmacol; 1970 Jul; 1(4):471-8. PubMed ID: 5524258
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacology of 1-(2-oxo-1-pyrrolidino)-4-(2-chloroethyl-methylamino)but-2-yne-HCl (DSO-16), I. Its central cholinomimetic and cholinolytic effects on mice.
    György L; Gellén B; Dóda M; Sterk L
    Acta Physiol Acad Sci Hung; 1971; 40(3):373-9. PubMed ID: 5147960
    [No Abstract]   [Full Text] [Related]  

  • 3. [On the antagonistic effect of pyrone compounds of the kava rhizome (Piper methysticum Forst) against 1,4-dipyrrolidino-2-butyne].
    Meyer HJ; Dierstein M
    Arzneimittelforschung; 1965 Nov; 15(11):1344-7. PubMed ID: 5899870
    [No Abstract]   [Full Text] [Related]  

  • 4. Acetylene compounds of potential pharmacological value. XVI. N-(perhydroazepinoalkynyl)- and N-(perhydroazocinoalkynyl)succinimides.
    Lindquist A; Lindgren S; Lindeke B; Karlén B; Dahlbom R; Blair MR
    Acta Pharm Suec; 1972 Apr; 9(2):93-8. PubMed ID: 5030544
    [No Abstract]   [Full Text] [Related]  

  • 5. Acetylene compounds of potential pharmacological value. XXIII. N-(1-Methyl-5-pyrrolidino-3-pentynyl)-substituted succinimide and 2-pyrrolidone.
    Lindgren S; Svensson U; Dahlbom R
    Acta Pharm Suec; 1975; 12(5-6):503-6. PubMed ID: 1217504
    [No Abstract]   [Full Text] [Related]  

  • 6. Stereospecificity of oxotremorine antagonists.
    Dahlbom R; Lindquist A; Lindgren S; Svensson U; Ringdahl B; Blair MR
    Experientia; 1974 Oct; 30(10):1165-7. PubMed ID: 4435124
    [No Abstract]   [Full Text] [Related]  

  • 7. N-(t-aminoalkynyl)-substituted pyrrolidones as oxotremorine antagonists.
    Lindgren S; Lindquist A; Lindeke B; Svensson U; Karlén B; Dahlbem R; Blair MR
    Experientia; 1970 Nov; 26(11):1232-3. PubMed ID: 5485292
    [No Abstract]   [Full Text] [Related]  

  • 8. Acetylene compounds of potential pharmacological value. XIX. N-(dialkylaminoalkynyl)-substituted succinimides and 2-pyrrolidones as partial cholinergic agonists.
    Svensson U; Dahlbom R
    Acta Pharm Suec; 1975; 12(3):209-14. PubMed ID: 1163240
    [No Abstract]   [Full Text] [Related]  

  • 9. Acetylene compounds of potential pharmacological value. XIV. N-(t-aminoalkynyl)-substituted succinimides and maleimides. A class of central anticholinergic agents.
    Karlèn B; Lindeke B; Lindgren S; Svensson KG; Dahlbom R; Jenden DJ; Giering JE
    J Med Chem; 1970 Jul; 13(4):651-7. PubMed ID: 5452427
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of elantrine, a new anti-Parkinsonism agent, on drug-induced tremor in mice.
    Ursillo RC; McCulloch JA
    Arch Int Pharmacodyn Ther; 1972 May; 197(1):132-40. PubMed ID: 5031571
    [No Abstract]   [Full Text] [Related]  

  • 11. Acetylene compounds of potential pharmacological value. XII. Central and peripheral anticholinergic activity of t-aminoalkynyl esters of some carboxylic acids.
    Dahlbom R; Erbing B; Olsson K; George R; Jenden DJ
    Acta Pharm Suec; 1969 Jun; 6(3):349-58. PubMed ID: 5824849
    [No Abstract]   [Full Text] [Related]  

  • 12. Synthesis and mass spectrometric investigations of metabolites of N-(5-pyrrolidino-pent-3-ynyl)succinimide (BL 14).
    Hallström G; Anderson E; Lindeke B
    Acta Pharm Suec; 1980; 17(1):31-54. PubMed ID: 7424535
    [No Abstract]   [Full Text] [Related]  

  • 13. Acetylene compounds of potential pharmacological value. XXX. Synthesis and pharmacological properties of N-(4-pyrrolidino-2-pentynyl)-substituted 2-pyrrolidone and succinimide.
    Resul B; Ringdahl B; Dahlbom R
    Acta Pharm Suec; 1979; 16(3):161-5. PubMed ID: 484249
    [No Abstract]   [Full Text] [Related]  

  • 14. The central and peripheral effectiveness of two oxotremorine-antagonists determined using oxotremorine-induced tremor and salivation.
    Eicholzer A; Ogren SO
    J Pharm Pharmacol; 1977 Oct; 29(10):609-11. PubMed ID: 21240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of various antihistamines on oxotremorine-induced hypothermia in mice.
    Gerald MC; Skau KA; Maickel RP
    Eur J Pharmacol; 1972 Jan; 17(1):189-93. PubMed ID: 4401430
    [No Abstract]   [Full Text] [Related]  

  • 16. [Action spectra of 3 anticholinergic drugs with preferential central activity (2 phenyl-2-isobutyl) ethyl pyrrolidone (1067 CERM), 2(ethyl n-propyl-amino ethyl alpha, alpha-diphenylglycolate (AP 1288) and dimethylamino-9-benziloxybicyclo (3,3,1)nonane (N1199)].
    Barthelemy C; Tremblay E; Frances H; Jacob J
    Therapie; 1972; 27(2):369-79. PubMed ID: 5084678
    [No Abstract]   [Full Text] [Related]  

  • 17. Acetylene compounds of potential pharmacological value. XXII. Base strength and biological activity in oxotremorine antagonists.
    Svensson U; Ringdahl B; Dahlbom R
    Acta Pharm Suec; 1975; 12(5-6):393-400. PubMed ID: 1217491
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of desmethylimipramine and other "anti-tremorine" drugs on the metabolism of tremorine and oxotremorine in rats and mice.
    Sjöqvist F; Hammer W; Schumacher H; Gillette J
    Biochem Pharmacol; 1968 Jun; 17(6):915-34. PubMed ID: 5661354
    [No Abstract]   [Full Text] [Related]  

  • 19. Synthesis and pharmacology of N-(4-diethylamino-2-butynyl)-succinimide (DKJ 21), a new central anticholinergic agent.
    Dahlbom R; Karlen B; George R; Jenden DJ
    Life Sci; 1966 Sep; 5(17):1625-31. PubMed ID: 5970685
    [No Abstract]   [Full Text] [Related]  

  • 20. Synthesis and pharmacology of 1-(2-thioxopyrrolidino)-4-pyrrolidino-2-butyne, the thiolactam analogue of oxotremorine.
    Lindeke B; Karlén B; Dahlbom R; Green R; Jenden DJ
    J Pharm Pharmacol; 1972 Jan; 24(1):25-31. PubMed ID: 4401313
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.